Chagas' disease - Can we stop the deaths?

New England Journal of Medicine

Volumn 355, Issue 8, 2006, Pages 760-761

  Maguire, James H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAZIL; CHAGAS DISEASE; GEOGRAPHIC DISTRIBUTION; HUMAN; MORTALITY; PRIORITY JOURNAL; SHORT SURVEY; TRIATOMINAE; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ADULT; AMERICAS; ANIMALS; BUNDLE-BRANCH BLOCK; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE TRANSMISSION; HUMANS; MIDDLE AGED; RISK ASSESSMENT; TRYPANOSOMA CRUZI;

EID: 33747821110     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp068130     Document Type: Short Survey

References (5)

1. Control of Chagas disease: report of a WHO expert committee. World Health Organ Tech Rep Ser 2002;905:1-109.
2. Maguire JH, Hoff R, Sherlock I, et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987;75:1140-5.
3. Andrade AL, Martelli CM, Oliveira RM, et al. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 2004;71:594-7.
4. Viotti R, Vigliano C, Lococo B, et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 2006;144:724-34.
5. El-Sayed NM, Myler PJ, Batholomeu DC, et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005;309:409-15.